Company · CIK 1880438

# AN2 Therapeutics, Inc.

| CIK | [1880438](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001880438) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | ANTX (Nasdaq) |
| First annual or quarterly report | 2022-05-10 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-294956 | Shelf Effective | 2026-04-09 | 2026-04-20 | 3 |
| 333-271174 | Shelf Effective | 2023-04-06 | 2023-08-16 | 4 |
| 333-263295 | IPO Final prospectus | 2022-03-04 | 2022-03-28 | 4 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-04-20 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1880438/999999999526001256/9999999995-26-001256-index.htm) Declared effective | 333-294956 | 9999999995-26-001256 |
| 2026-04-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1880438/000119312526164095/0001193125-26-164095-index.htm) Shelf takedown | 333-294956 | 0001193125-26-164095 |
| 2026-04-09 | [S-3](https://www.sec.gov/Archives/edgar/data/1880438/000119312526149869/0001193125-26-149869-index.htm) Shelf registered | 333-294956 | 0001193125-26-149869 |
| 2023-08-16 | [424B5](https://www.sec.gov/Archives/edgar/data/1880438/000119312523214364/0001193125-23-214364-index.htm) Shelf takedown | 333-271174 | 0001193125-23-214364 |
| 2023-04-14 | [424B5](https://www.sec.gov/Archives/edgar/data/1880438/000119312523100832/0001193125-23-100832-index.htm) Shelf takedown | 333-271174 | 0001193125-23-100832 |
| 2023-04-13 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1880438/999999999523000930/9999999995-23-000930-index.htm) Declared effective | 333-271174 | 9999999995-23-000930 |
| 2023-04-06 | [S-3](https://www.sec.gov/Archives/edgar/data/1880438/000119312523094152/0001193125-23-094152-index.htm) Shelf registered | 333-271174 | 0001193125-23-094152 |
| 2022-03-28 | [424B4](https://www.sec.gov/Archives/edgar/data/1880438/000119312522085459/0001193125-22-085459-index.htm) Final prospectus | 333-263295 | 0001193125-22-085459 |
| 2022-03-24 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1880438/999999999522000716/9999999995-22-000716-index.htm) Declared effective | 333-263295 | 9999999995-22-000716 |
| 2022-03-21 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1880438/000119312522080012/0001193125-22-080012-index.htm) Amendment | 333-263295 | 0001193125-22-080012 |
| 2022-03-04 | [S-1](https://www.sec.gov/Archives/edgar/data/1880438/000119312522066048/0001193125-22-066048-index.htm) Registration filed | 333-263295 | 0001193125-22-066048 |
| 2021-09-24 | [DRS](https://www.sec.gov/Archives/edgar/data/1880438/000095012321012609/0000950123-21-012609-index.htm) Draft made public | 377-05527 | 0000950123-21-012609 |

[All filings of this company](https://equitycapital.markets/filings?cik=1880438) · [CSV](https://equitycapital.markets/filings.csv?cik=1880438)

---
Source page: https://equitycapital.markets/company/1880438 · Data: U.S. SEC EDGAR · CC BY 4.0